Fundraising Fox
Medicinal Genomics
Beverly, US · Founded 2009 · 1 known investors
Find your way into Medicinal Genomics
Sign up to see every warm intro you have to Medicinal Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Medicinal Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Medicinal Genomics provides microbial and plant testing solutions for the cannabis, nutraceutical, and food safety industries through validated qPCR assays and automated liquid handling platforms. Their offerings enable rapid pathogen detection and species identification with turnaround times measured in hours rather than days.
Founders & leadership
Medicinal Genomics was founded in 2009 by Kevin J. McKernan.
KJ
Kevin J. McKernanFounder
PC
Patrick CostelloExecutive
BL
Brendan L. McKernanExecutive
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$21.5M disclosed across 4 rounds · 2014–2020
▶$2.7MraisedApr 2021 · 65 investors · BiotechnologyRule 506(b)
▶$2.7MraisedApr 2021 · 65 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick CostelloExecutive Officer
- Charles M FarkasDirector
- Richard McKernanDirector
- Philip ChapmanDirector
- Mark H DeBloisDirector
- Brendan L McKernanExecutive Officer, Director
- Richard UptonDirector
- Kevin J. McKernanExecutive Officer
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedNov 2017 · 43 investors · BiotechnologyRule 506(b)
▶$5MraisedNov 2017 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard T. McKernanDirector
- Philip ChapmanDirector
- Charles M. FarkasDirector
- Mark H. DeBloisDirector
- Richard UptonDirector
- Brendan L. McKernanExecutive Officer, Director
- Patrick CostelloExecutive Officer
- Kevin J. McKernanExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.5MraisedJun 2015 · 3 investors · BiotechnologyRule 506(b)
▶$7.5MraisedJun 2015 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard T. McKernanDirector
- Emery G. OlcottDirector
- Patrick B. CostelloExecutive Officer
- John J. AltorelliDirector
- Stephen M. McLeanDirector
- Philip ChapmanDirector
- Brendan L. McKernanExecutive Officer, Director
- R. Brian McKernanExecutive Officer, Director
- Richard UptonDirector
- Amount sold
- $7.5M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MraisedJun 2014 · 44 investors · BiotechnologyRule 506(b)
▶$6.3MraisedJun 2014 · 44 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard T. McKernanDirector
- Patrick B. CostelloExecutive Officer
- R. Brian McKernanExecutive Officer, Director
- Philip ChapmanDirector
- Richard UptonDirector
- Emery G. OlcottDirector
- John J. AltorelliDirector
- Stephen M. McLeanDirector
- Brendan L. McKernanExecutive Officer, Director
- Amount sold
- $6.3M
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Medicinal Genomics went on to found or lead other companies.
Frequently asked questions
- What does Medicinal Genomics do?
- Medicinal Genomics provides microbial and plant testing solutions for the cannabis, nutraceutical, and food safety industries through validated qPCR assays and automated liquid handling platforms. Their offerings enable rapid pathogen detection and species identification with turnaround times measured in hours rather than days.
- Who founded Medicinal Genomics?
- Medicinal Genomics was founded by Kevin J. McKernan in 2009.
- Who are Medicinal Genomics's investors?
- Medicinal Genomics's investors include Harbor Light Capital Partners.
- How much funding has Medicinal Genomics raised?
- Medicinal Genomics has disclosed $21.5M raised across 4 rounds.
- Where is Medicinal Genomics headquartered?
- Medicinal Genomics is headquartered in Beverly, US.